Ziemer Ophthalmic Systems

What Ziemer Ophthalmic Systems does

Ziemer Ophthalmic Systems AG is a privately held Swiss medical device company founded in 1998 that designs, manufactures, and sells high-end femtosecond laser systems and diagnostic platforms for ophthalmic surgery. The company's core technology centers on a proprietary low-energy femtosecond laser concept operating in the MHz repetition rate range, which the company positions as differentiated from higher-energy competitors by enabling smoother stromal beds, reduced tissue damage, and faster visual recovery. Its product portfolio spans laser systems (FEMTO Z8 NEO, FEMTO LDV Z8, Z6, Z4, AQUARIUZ wet ablation platform), diagnostic devices (GALILEI G4, G6), and workflow software (FlowSuite), supporting refractive surgery (Z-LASIK, CLEAR Supra, AQUA LASIK/PRK), cataract surgery (CLARIGS), and therapeutic ophthalmic procedures including pediatric cataract surgery — an application for which Ziemer holds the only CE-marked femtosecond laser indication.

The company sells capital equipment directly to eye care professionals, hospitals, and clinics through wholly-owned regional subsidiaries in Switzerland (HQ), the United States, Germany, and China, complemented by a global distributor network for additional geographies. Revenue is generated primarily through hardware sales of laser and diagnostic systems, with recurring service/support contracts and FlowSuite software licenses providing secondary, ongoing streams. Pricing is not publicly disclosed, consistent with enterprise field sales to clinical buyers. Ziemer invests in clinical evidence generation, peer-reviewed publications, and major ophthalmology congresses (ESCRS, satellite symposiums) as core go-to-market channels, reflecting the clinical-evidence-driven adoption model typical of premium surgical capital equipment.

Founded and still led by Frank Ziemer as founder, president, and CEO, the company operates with an estimated 51–100 employees and reports no parent company, public listing, or external venture or private equity funding rounds. Recent activity in 2025 includes the launch of Z8 Platforms for pediatric cataract surgery, a new patient education website (ziemerpatients.com), and satellite symposium presence at ESCRS 2025 in Copenhagen, indicating active product and brand investment despite no disclosed financial transactions.

Name

Ziemer Ophthalmic Systems

Legal name

Ziemer Ophthalmic Systems AG

Website

https://ziemergroup.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

51–100 employees

Short description

Ziemer Ophthalmic Systems AG is a privately held Swiss medical device company that designs and sells femtosecond laser systems, diagnostic platforms, and workflow software for refractive, cataract, and therapeutic ophthalmic surgery, serving eye care professionals, hospitals, and clinics globally.

Ownership category

akta.pro rank

Product category

Ophthalmic Surgical Equipment

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Refractive Surgery Systems (Excimer/Femtosecond Lasers, Phakic IOL Systems, Wavefront/Guidance) (HLAHAJAG)

akta.pro secondary industry

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)

Keywords

• Femtosecond laser systems
• Ophthalmic diagnostic devices
• Cataract surgery equipment
• Refractive surgery lasers
• Surgical planning software

Headquarters

HQ city

Bellmund

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Laser Systems Sales: Sale of femtosecond laser platforms including FEMTO Z8 NEO, FEMTO LDV Z8, FEMTO LDV Z6, FEMTO LDV Z4, and AQUARIUZ wet ablation laser to eye care professionals, hospitals, and clinics.
2. Diagnostic Device Sales: Sale of diagnostic devices including GALILEI G4 and GALILEI G6 platforms for ophthalmic diagnostics and surgical planning.
3. Service and Support Contracts: Ongoing support, maintenance, and service contracts for installed base of laser and diagnostic systems.
4. Planning Software Licenses: Licensing of FlowSuite planning software and other software solutions for surgical planning and workflow management.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Ziemer Ophthalmic Systems AG designs, manufactures, and sells high-end femtosecond laser platforms (FEMTO Z8 NEO, FEMTO LDV Z8/Z6/Z4), wet ablation laser systems (AQUARIUZ), diagnostic devices (GALILEI G4, GALILEI G6), and surgical planning software (FlowSuite) for ophthalmic surgeons performing refractive, cataract, and therapeutic eye surgery.

Product overview

Ziemer Ophthalmic Systems is a Swiss company specializing in high-end ophthalmic lasers, diagnostic devices, and customized surgical solutions for eye care professionals. The portfolio centers on femtosecond laser platforms (FEMTO Z8 NEO, FEMTO LDV Z8/Z6/Z4) with proprietary low energy technology operating in the MHz repetition rate range. The AQUARIUZ wet ablation laser platform enables scentless, gentle refractive procedures. Diagnostic devices (GALILEI G4, G6) integrate with planning software (FlowSuite) for seamless surgical workflow. The company serves three main treatment areas: Refractive surgery (Z-LASIK, AQUA LASIK/PRK, CLEAR Supra), Cataract surgery (CLARIGS), and Therapeutic applications, positioning Ziemer as a comprehensive surgical ecosystem rather than isolated products.

Differentiator

Problem solved

Functional benefit

Brands

• CLARIGS: Cataract Laser Advanced Robotic Image-Guided Surgery - an innovative system for cataract surgery combining Swiss engineering, low energy laser technology, and compact design with intra-operative OCT imaging.
• Z-LASIK
• CLEAR Supra
• AQUA Treatments
• AQUARIUZ
• FEMTO Z8 NEO
• FlowSuite
• GALILEI

Products and services

• FEMTO Z8 NEO Multipurpose femtosecond laser platform for refractive, therapeutic, and cataract surgery, featuring seamless workflow integration with any excimer laser on the market and intraoperative OCT imaging. Sold to eye care professionals, hospitals, and clinics.
• FEMTO LDV Z8 Femtosecond laser platform with low energy concept for precise tissue interaction and minimal side effects, supporting refractive and cataract surgery applications.
• FEMTO LDV Z6 Femtosecond laser system offering Ziemer's low energy technology for refractive surgery applications.
• FEMTO LDV Z4 Entry-level femtosecond laser platform with Ziemer's proprietary low energy concept for corneal surgery.
• AQUARIUZ Wet ablation laser platform enabling scentless and efficient refractive surgery with AQUA LASIK and AQUA PRK procedures, featuring innovative Wet Ablation Technology that maintains naturally hydrated cornea treatment.
• GALILEI G4 Holistic diagnostic platform for corneal mapping and analysis, integrated with Ziemer's surgical workflow.
• GALILEI G6 Advanced diagnostic platform building on GALILEI technology for comprehensive eye diagnostics.
• FlowSuite Planning software that streamlines surgical workflow by connecting diagnostic and surgical laser devices into a unified ecosystem, minimizing human-derived errors.

Quantifiable outcome

• Only 0.28% intraoperative complications across >1,800 eyes (0.17% anterior tears, 0.11% PCR) in FLACS procedures
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Carl Zeiss Meditec: Markets the VisuMax femtosecond laser platform for refractive surgery (including SMILE lenticule extraction) and a wide ophthalmic surgical microscope/diagnostic portfolio, overlapping with Ziemer's FEMTO Z8 and GALILEI diagnostics in refractive and cataract workflows.
• Topcon Healthcare: Major ophthalmic diagnostic and imaging company whose anterior segment and surgical planning technologies intersect with Ziemer's GALILEI and FlowSuite platforms, particularly in refractive surgery planning workflows.
• NIDEK: Japanese ophthalmic equipment manufacturer with broad portfolio of refractive lasers, diagnostic devices, and cataract surgery systems that overlap with Ziemer's FEMTO, GALILEI, and AQUARIUZ product families.
• Alcon: Global leader in eye care with a portfolio that includes the LensX/Lensar femtosecond cataract laser platforms and WaveLight refractive excimer systems, directly competing with Ziemer's FEMTO and CLARIGS offerings across refractive and cataract surgery.
• Johnson & Johnson Vision: Operates the iFS Advanced Femtosecond Laser (originally IntraLase) for LASIK flap creation and a broad cataract IOL portfolio, competing head-to-head with Ziemer's FEMTO Z8 and CLARIGS in both refractive and cataract surgery markets.
• Bausch + Lomb: Sells the Victus femtosecond laser platform for cataract and refractive surgery along with a broad IOL and pharmaceutical ophthalmology portfolio, directly competing with Ziemer's CLARIGS cataract and FEMTO refractive platforms.

Direct peers

• LENSAR: U.S.-listed pure-play in femtosecond laser cataract surgery (ALLY system), directly competing with Ziemer's CLARIGS platform in the FLACS market with a focus on image-guided cataract workflows.
• SCHWIND eye-tech-solutions: German manufacturer of excimer lasers (AMARIS) for refractive surgery and adjacent diagnostic devices, competing with Ziemer's refractive laser and AQUARIUZ platforms particularly in the European refractive surgery market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ziemergroup
• Facebookfacebook.com/ziemerophthalmology

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ziemer Ophthalmic Systems